4HWT.B | TARS

General Structure Information 4hwt TARS crystal structure of human threonyl-trna synthetase bound to a novel inhibitor 2.3Å AUTH M.TENG,M.T.HILGERS,M.L.CUNNINGHAM,A.BORCHARDT,J.B.LOCKE,AUTH 2 S.ABRAHAM,G.HALEY,B.P.KWAN,C.HALL,G.W.HOUGH,K.J.SHAW,J.FINNTITL IDENTIFICATION OF BACTERIA-SELECTIVE THREONYL-TRNATITL 2 SYNTHETASE SUBSTRATE INHIBITORS BY STRUCTURE-BASED DESIGN.REF J.MED.CHEM. V. 56 1748 2013REFN ISSN 0022-2623PMID 23362938DOI 10.1021/JM301756M Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Mapped Variants

See Details
3II5.A | BRAF

General Structure Information 3ii5 BRAF the complex of wild-type b-raf with pyrazolo pyrimidine inhibitor 2.79Å AUTH D.M.BERGER,N.TORRES,M.DUTIA,D.POWELL,G.CISZEWSKI,AUTH 2 A.GOPALSAMY,J.I.LEVIN,K.H.KIM,W.XU,J.WILHELM,Y.HU,AUTH 3 K.COLLINS,L.FELDBERG,S.KIM,E.FROMMER,AUTH 4 D.WOJCIECHOWICZ,R.MALLONTITL NON-HINGE-BINDING PYRAZOLO[1,5-A]PYRIMIDINES ASTITL 2 POTENT B-RAF KINASE INHIBITORS.REF BIOORG.MED.CHEM.LETT. V. 19 6519 2009REFN ISSN 0960-894XPMID 19864136DOI 10.1016/J.BMCL.2009.10.049 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details